Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-222115
Abstract: Monoclonal antibodies (MAbs), convalescent plasma (CP) and hyperimmune intravenous immunoglobulins are routinely used to treat COVID19 patients with autoimmune disorders, organ transplant patients and patients on immunosuppressive drugs. The recent emergence of rapidly spreading SARSCoV2… read more here.
Keywords: omicron; neutralisation; sarscov2; neutralisation titres ... See more keywords